Publications 2002
Balancing susceptibility to infection and autoimmunity: a role for leptin?
Matarese G, La Cava A, Sanna V, Lord GM, Lechler RI, Fontana S, Zappacosta S.
Trends Immunol. 2002 Apr;23(4):182-7.
Leptin accelerates autoimmune diabetes in female NOD mice.
Matarese G, Sanna V, Lechler RI, Sarvetnick N, Fontana S, Zappacosta S, La Cava A.
Diabetes. 2002 May;51(5):1356-61.
Leptin inhibits the anti-CD3-driven proliferation of peripheral blood T cells but enhances the production of proinflammatory cytokines.
Lord GM, Matarese G, Howard JK, Bloom SR, Lechler RI.
J Leukoc Biol. 2002 Aug;72(2):330-8.
Serum leptin and CD4+ T lymphocytes in HIV+ children during highly active antiretroviral therapy.
Matarese G, Castelli-Gattinara G, Cancrini C, Bernardi S, Romiti ML, Savarese C, Di Giacomo A, Rossi P, Racioppi L.
Clin Endocrinol (Oxf). 2002 Nov;57(5):643-6.
Beneficial effects of leptin on obesity, T cell hyporesponsiveness, and neuroendocrine/metabolic dysfunction of human congenital leptin deficiency.
Farooqi IS, Matarese G, Lord GM, Keogh JM, Lawrence E, Agwu C, Sanna V, Jebb SA, Perna F, Fontana S, Lechler RI, DePaoli AM, O'Rahilly S.
J Clin Invest. 2002 Oct;110(8):1093-103.
Leptin as a novel therapeutic target for immune intervention.
Matarese G, Sanna V, Fontana S, Zappacosta S.
Curr Drug Targets Inflamm Allergy. 2002 Mar;1(1):13-22.
